Loubna Mhamdi

805 total citations
10 papers, 533 citations indexed

About

Loubna Mhamdi is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Loubna Mhamdi has authored 10 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Cancer Research. Recurrent topics in Loubna Mhamdi's work include Cholesterol and Lipid Metabolism (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Loubna Mhamdi is often cited by papers focused on Cholesterol and Lipid Metabolism (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Loubna Mhamdi collaborates with scholars based in France, United States and Jordan. Loubna Mhamdi's co-authors include Michel Vernay, M. Novak, Beverley Balkau, Jean Tichet, E Eschwège, Sylviane Vol, Sandrine Silvente‐Poirot, Marc Poirot, Philippe de Médina and Michaël R. Paillasse and has published in prestigious journals such as Nature Communications, Cancer Research and Clinical Cancer Research.

In The Last Decade

Loubna Mhamdi

10 papers receiving 516 citations

Peers

Countries citing papers authored by Loubna Mhamdi

Since Specialization

Citations

This map shows the geographic impact of Loubna Mhamdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loubna Mhamdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loubna Mhamdi more than expected).

Fields of papers citing papers by Loubna Mhamdi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loubna Mhamdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loubna Mhamdi. The network helps show where Loubna Mhamdi may publish in the future.

Co-authorship network of co-authors of Loubna Mhamdi

This figure shows the co-authorship network connecting the top 25 collaborators of Loubna Mhamdi. A scholar is included among the top collaborators of Loubna Mhamdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loubna Mhamdi. Loubna Mhamdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	LBA87 Phase II LITESPARK-003 study of belzutifan in combination with cabozantinib for advanced clear cell renal cell carcinoma (ccRCC) 2023 ·Annals of Oncology ·Toni K. Choueiri, Todd M. Bauer, Jaime R. Merchan, David F. McDermott, Robert A. Figlin, Edward Arrowsmith, M. Dror Michaelson, Elisabeth I. Heath, (unknown), Shuang G. Zhao, Loubna Mhamdi, Rodolfo F. Perini, Donna Vickery, Scott S. Tykodi	9
2	The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas 2019 ·Clinical Cancer Research ·Sabrina Croce, Tom Lesluyes, Carine Valle, Loubna Mhamdi, (unknown), Gaëlle Pérot, Eberhard Stoeckle, Jean‐Christophe Noël, (unknown), Mojgan Devouassoux‐Shisheboran, Denis Querleu, Frédéric Guyon, Anne Floquet, Camille Chakiba, Laétitia Mayeur, (unknown), Gaëtan MacGrogan, Isabelle Soubeyran, Sophie Le Guellec, Frédéric Chibon	15
3	Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer – the INNODIAG study 2015 ·BMC Medical Genomics ·(unknown), Carine Valle, Magali Lacroix‐Triki, Lyamine Hedjazi, (unknown), (unknown), Delphine Labourdette, (unknown), Loubna Mhamdi, (unknown), Thomas Filleron, Gilles Favre, Jean François, (unknown), Véronique Anton Leberre	18
4	Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties 2013 ·Nature Communications ·Philippe de Médina, Michaël R. Paillasse, Grégory Segala, Maud Voisin, Loubna Mhamdi, Florence Dalenc, Magali Lacroix‐Triki, Thomas Filleron, Frédéric Pont, Talal Al Saati, Christophe Morisseau, Bruce D. Hammock, Sandrine Silvente‐Poirot, Marc Poirot	102
5	Formation of the eIF4F Translation–Initiation Complex Determines Sensitivity to Anticancer Drugs Targeting the EGFR and HER2 Receptors 2011 ·Cancer Research ·(unknown), Yann Bergé, Ben Allal, Thomas Filleron, Sandra Pierredon, Anne Cammas, Samantha Beck, Loubna Mhamdi, (unknown), Gilles Favre, Jean‐Pierre Delord, Henri Roché, Florence Dalenc, Magali Lacroix‐Triki, Stéphan Vagner	45
6	Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion 2009 ·Journal of Lipid Research ·Michaël R. Paillasse, Philippe de Médina, (unknown), Loubna Mhamdi, Marc Poirot, Sandrine Silvente‐Poirot	60
7	Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism 2008 ·Molecular Cancer Therapeutics ·Bruno Payré, Philippe de Médina, Nadia Boubekeur, Loubna Mhamdi, Justine Bertrand‐Michel, François Tercé, Isabelle Fourquaux, Dominique Goudounèche, Michel Record, Marc Poirot, Sandrine Silvente‐Poirot	51
8	Insights into the Cholecystokinin 2 Receptor Binding Site and Processes of Activation 2006 ·Molecular Pharmacology ·Michaël R. Paillasse, Céline Deraeve, Philippe de Médina, Loubna Mhamdi, Gilles Favre, Marc Poirot, Sandrine Silvente‐Poirot	7
9	Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study 2005 ·European Journal of Clinical Nutrition ·B. Balkau, David Sapinho, (unknown), Loubna Mhamdi, M. Cailleau, (unknown), Marie‐Aline Charles, (unknown)	21
10	The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study 2003 ·Diabetes & Metabolism ·Beverley Balkau, Michel Vernay, Loubna Mhamdi, M. Novak, (unknown), Sylviane Vol, Jean Tichet, E Eschwège	205

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact